Log In
Print
BCIQ
Print
Print this Print this
 

CMX-2043

  Manage Alerts
Collapse Summary General Information
Company Ischemix Inc.
DescriptionSmall molecule that modulates the protein kinase B (PKB; PKBA; AKT; AKT1) pathway
Molecular Target Protein kinase B (PKB) (PKBA) (AKT) (AKT1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationIschemia / reperfusion injury
Indication DetailsPrevent contrast-induced acute kidney injury (AKI); Prevent peri-operative ischemia/reperfusion injury in patients undergoing percutaneous coronary intervention (PCI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today